Understanding how bacteria communicate and affect the immune system
Nucleic Acids and Pneumococcal Extracellular Vesicles: the Who, How and Why?
This study is looking at how a harmful germ called Streptococcus pneumoniae talks to other bacteria and our cells using tiny bubbles, which could help us understand how it causes infections and how we might treat them better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Carnegie-Mellon University NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11110461 on NIH RePORTER |
What this research studies
This research investigates how Streptococcus pneumoniae, a harmful bacterium, uses tiny vesicles to communicate with other bacteria and human cells. By studying these vesicles, the research aims to uncover how they carry genetic material that can influence bacterial behavior and contribute to disease. The project will explore the mechanisms behind this communication and how it affects the immune response, potentially leading to new therapeutic strategies. Patients may benefit from insights gained about bacterial infections and their treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by Streptococcus pneumoniae or those at high risk for such infections.
Not a fit: Patients with infections caused by other types of bacteria unrelated to Streptococcus pneumoniae may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies targeting bacterial communication, improving treatment options for infections caused by Streptococcus pneumoniae.
How similar studies have performed: Other research has shown promise in targeting bacterial communication pathways, suggesting that this approach could yield significant insights and advancements.
Where this research is happening
Pittsburgh, United States
- Carnegie-Mellon University — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Hiller, Natalia Luisa — Carnegie-Mellon University
- Study coordinator: Hiller, Natalia Luisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.